DAWN BAIRD: Open Payments
NPI 1265439095 · AYER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 75 payments from 11 companies in 2025. Trend: 2023 $636 · 2024 $781 · 2025 $1,374
Food & beverage: $1,309Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $497 |
| Janssen Biotech, Inc. | 19 | $389 |
| PFIZER INC. | 9 | $141 |
| Lilly USA, LLC | 4 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Organon LLC | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TREMFYA, SKYRIZI, RINVOQ, CIBINQO, Sotyktu, EBGLYSS, NEMLUVIO, TALTZ.
Industry payments across MA — which companies pay providers there.
